Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis

Journal of Rheumatology

Volumn 36, Issue 10, 2009, Pages 2149-2157

  Burkhardt, Jana ^a   Petit Teixeira, Elisabeth ^b   Teixeira, Vitor Hugo ^b   Kirsten, Holger ^a   Garnier, Sophie ^c   Ruehle, Sandra ^a   Oeser, Christian ^a   Wolfram, Grit ^a   Scholz, Markus ^a   Migliorini, Paola ^d   Balsa, Alejandro ^e   Westhovens, René ^f   Barrera, Pilar ^g   Alves, Helena ^h   Pascual Salcedo, Dora ^e   Bombardieri, Stefano ^d   Dequeker, Jan ^f   Radstake, Timothy R ^g   Van Riel, Piet ^g   Van De Putte, Leo ^g   Bardin, Thomas ⁱ   Prum, Bernard ^j   Buchegger Podbielski, Ulrike ^k   Emmrich, Frank ^l   Melchers, Inga ^k   Cornelis, François ^b   Ahnert, Peter ^a   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

^b University of Evry Val d'Essonne   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITY OF PISA   (Italy)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^h HOSPITAL DE SÃO JOÃO   (Portugal)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

^j UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^k UNIVERSITY OF FREIBURG   (Germany)

^l FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

more..

Author keywords

Genetic predisposition to disease; Genetic studies; Polymorphism; Rheumatoid arthritis; Tissue inhibitor of metalloproteinases

Indexed keywords

CD40 LIGAND; CD99 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; INITIATION FACTOR 2; INTERLEUKIN 9 RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UBIQUITIN PROTEIN LIGASE; X LINKED INHIBITOR OF APOPTOSIS;

ANTIBODY DETECTION; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY ASSESSMENT; FEMALE; FRANCE; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, X; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-9; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 70450177659     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090059     Document Type: Article

References (59)

1. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999;42:1071-1079 (Pubitemid 29268942)
2. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-37 (Pubitemid 30368210)
3. Lockshin MD. Invited review: sex ratio and rheumatic disease. J Appl Physiol 2001;91:2366-2373
4. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003;423:825-837
5. Orstavik KH. Skewed X inactivation in healthy individuals and in different diseases. Acta Paediatr Suppl 2006;95:24-29
6. Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005;175:575-578 (Pubitemid 40894631)
7. Brix TH, Knudsen GP, Kristiansen M, Kyvik KO, Orstavik KH, Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 2005;90:5949-5953 (Pubitemid 41606510)
8. Ranke MB, Saenger P. Turner's syndrome. Lancet 2001;358:309-314
9. John S, Shephard N, Liu G, Zeggini E, Cao M, Chen W, et al. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet 2004;75:54-64. (Pubitemid 38801901)
10. Osorio YF, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C, Cailleau-Moindrault S, et al. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum 2004;50:2757-2765 (Pubitemid 39209512)
11. Citores MJ, Rua-Figueroa I, Rodriguez-Gallego C, Durantez A, Garcia-Laorden MI, Rodriguez-Lozano C, et al. The dinucleotide repeat polymorphism in the 3'UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus. Ann Rheum Dis 2004;63:310-317 (Pubitemid 38250676)
12. Sohn HW, Shin YK, Lee IS, Bae YM, Suh YH, Kim MK, et al. CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. J Immunol 2001;166:787-794 (Pubitemid 32060229)
13. Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI, et al. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol 1997;159:2250-2258
14. Pettersen RD, Bernard G, Olafsen MK, Pourtein M, Lie SO. CD99 signals caspase-independent T cell death. J Immunol 2001;166:4931-4942
15. Roll-Mecak A, Alone P, Cao C, Dever TE, Burley SK. X-ray structure of translation initiation factor eIF2-gamma: implications for tRNA and eIF2-alpha binding. J Biol Chem 2004;279:10634-10642 (Pubitemid 38372675)
16. Clemens MJ. Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis. Prog Mol Subcell Biol 2001;27:57-89.
17. Baier A, Meineckel I, Gay S, Pap T. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 2003;15:274-279
18. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-1638
19. Demoulin JB, Renauld JC. Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol 1998;16:345-364 (Pubitemid 28102260)
20. De Smedt M, Verhasselt B, Kerre T, Vanhecke D, Naessens E, Leclercq G, et al. Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development. J Immunol 2000;164:1761-1767 (Pubitemid 30108727)
21. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-815 (Pubitemid 24209481)
22. Rifkin DB, Gross JL, Moscatelli D, Gabrielides C. The involvement of proteases and protease inhibitors in neovascularization. Acta Biol Med Ger 1981;40:1259-1263
23. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
24. Yamada R, Tanaka T, Unoki M, Nagai T, Sawada T, Ohnishi Y, et al. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 2001;68:674-685 (Pubitemid 32202762)
25. Meijer MJ, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Hommes DW, Verspaget HW. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 2007;13:2960-2966
26. Indelicato M, Chiarenza V, Libra M, Malaponte G, Bevelacqua V, Marchini M, et al. Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients. J Clin Lab Anal 2006;20:173-176 (Pubitemid 44412088)
27. Takahashi E, Ayusawa D, Kaneda S, Itoh Y, Seno T, Hori T. The human ubiquitin-activating enzyme E1 gene (UBE1) mapped to band Xp11.3-p11.23 by fluorescence in situ hybridization. Cytogenet Cell Genet 1992;59:268-269
28. Pfleger CM, Harvey KF, Yan H, Hariharan IK. Mutation of the gene encoding the ubiquitin activating enzyme Uba1 causes tissue overgrowth in Drosophila. Fly (Austin) 2007;1:95-105.
29. Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006;444:110-114 (Pubitemid 44684766)
30. Jacq L, Garnier S, Dieude P, Michou L, Pierlot C, Migliorini P, et al. The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther 2007;9:R63.
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
32. Wenzel T, Elssner T, Fahr K, Bimmler J, Richter S, Thomas I, et al. Genosnip: SNP genotyping by MALDI-TOF MS using photocleavable oligonucleotides. Nucleosides Nucleotides Nucleic Acids 2003;22:1579-1581 (Pubitemid 37139449)
33. Kirsten H, Dienst S, Emmrich F, Ahnert P. CalcDalton: a tool for multiplex genotyping primer design for single-base extension reactions using cleavable primers. Biotechniques 2006;40:158,160,162.
34. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-516 (Pubitemid 23311321)
35. Lathrop GM. Estimating genotype relative risks. Tissue Antigens 1983;22:160-166
36. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265 (Pubitemid 40202029)
37. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219.
38. Horvath S, Laird NM, Knapp M. The transmission/disequilibrium test and parental-genotype reconstruction for X-chromosomal markers. Am J Hum Genet 2000;66:1161-1167 (Pubitemid 30470516)
39. Wellcome Trust Case-Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678
40. Julia A, Ballina J, Cañete JD, Balsa A, Tornero-Molina J, Naranjo A, et al. Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum 2008;58:2275-2286
41. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005;77:1044-1060 (Pubitemid 41698524)
42. Yamada R, Tanaka T, Unoki M, Nagai T, Sawada T, Ohnishi Y, et al. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 2001;68:674-685 (Pubitemid 32202762)
43. Okada Y, Nagase H, Harris ED Jr. Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. J Rheumatol 1987;14:41-42
44. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
45. Yayon A, Klagsbrun M. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proc Natl Acad Sci USA 1990;87:5346-5350 (Pubitemid 20260176)
46. Jackson CJ, Arkell J, Nguyen M. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis 1998;57:158-161 (Pubitemid 28244255)
47. Lyon MF. X-chromosome inactivation and human genetic disease. Acta Paediatr Suppl 2002;91:107-112 (Pubitemid 36174161)
48. Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B. Xist RNA and the mechanism of X chromosome inactivation. Annu Rev Genet 2002;36:233-278
49. Heard E. Delving into the diversity of facultative heterochromatin: the epigenetics of the inactive X chromosome. Curr Opin Genet Dev 2005;15:482-489 (Pubitemid 41262403)
50. Hawi Z, Mynett-Johnson L, Gill M, Murphy V, Straubl RE, Kendler KS, et al. Pseudoautosomal gene: possible association with bipolar males but not with schizophrenia. Psychiatr Genet 1999;9:129-134
51. Melen E, Gullsten H, Zucchelli M, Lindstedt A, Nyberg F, Wickman M, et al. Sex specific protective effects of interleukin-9 receptor haplotypes on childhood wheezing and sensitisation. J Med Genet 2004;41:e123.
52. Grasso L, Huang M, Sullivan CD, Messler CJ, Kiser MB, Dragwa CR, et al. Molecular analysis of human interleukin-9 receptor transcripts in peripheral blood mononuclear cells. Identification of a splice variant encoding for a nonfunctional cell surface receptor. J Biol Chem 1998;273:24016-24024 (Pubitemid 28435742)
53. Soussi-Gounni A, Kontolemos M, Hamid Q. Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 2001;107:575-582 (Pubitemid 32397739)
54. Bauer JH, Liu KD, You Y, Lai SY, Goldsmith MA. Heteromerization of the gamma-c chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem 1998;273:9255-9260
55. Ivashkiv LB, Hu X. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? Arthritis Rheum 2003;48:2092-2096
56. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38:209-213 (Pubitemid 43177235)
57. Lose F, Thompson PJ, Duffy D, Stewart GA, Kedda MA. A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax 2005;60:623-628 (Pubitemid 41129058)
58. Kauppi P, Laitinen T, Ollikainen V, Mannila H, Laitinen LA, Kere J. The IL9R region contribution in asthma is supported by genetic association in an isolated population. Eur J Hum Genet 2000;8:788-792 (Pubitemid 30767681)
59. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005;434:400-404 (Pubitemid 40469185)